Vyepti®
What is Vyepti®?
Vyepti® is an intravenous (IV) therapy approved for the preventive treatment of migraine in adults. It works by targeting and blocking calcitonin gene-related peptide (CGRP), a protein that plays a major role in triggering migraine attacks through inflammation and blood vessel dilation in the brain. By inhibiting CGRP, Vyepti® helps prevent migraines before they start, reducing how often they occur, how severe they are, and how long they last.
How does Vyepti® work?
Vyepti® blocks CGRP, helping to prevent migraine-related inflammation and pain. It can also help to lowers the frequency, intensity, and duration of migraine attacks over time. Vyepti® is a long-acting preventive option with IV infusions given just four times a year.
How much does Vyepti® cost?
Vyepti® cost can vary depending on several factors including insurance status and insurance provider. Our team at Rocky Mountain MS Clinic are committed to lowering costs and improving access for our patients.
We work with virtually all leading commercial insurance providers in the greater Intermountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, DMBA, EMI Health, Humana, PEHP Health & Benefits, Select Health, as Tricare, as well as Medicaid and Medicare.
We’re here to make treatment more affordable and less stressful. Our team takes care of prior authorizations and benefits verification for you, and we’ll personally guide you through copay assistance and foundation support programs to help lower your out-of-pocket costs.
Why Patients Choose Rocky Mountain Infusion Center to Receive Their Vyepti® Infusion:
Clinical Excellence and Neurological Expertise
Our infusion center is proud to have a board-certified neurologist on-site, along with a team of BSN-prepared and Multiple Sclerosis-certified Registered Nurses, all committed to delivering the highest standard of care for our patients.
Lower Costs and Financial Assistance
We handle prior-authorization, benefits verification, and guide patients through copay assistance and foundation programs to reduce out-of-pocket costs. Additional financial help may be available if you qualify — just ask, and we’ll help you explore every option.
A Cigna report recently found that with a physician-owned infusion site, like RMMSC’s Infusion Center, patients see much lower out-of-pocket and overall costs than they would at a hospital outpatient infusion center.
Established leader in MS & Neurological care
35+ years in the Intermountain region, serving thousands of individuals with MS and other neurological disorders.
Important Info
Migraine
Migraine: Approved on February 22, 2020
Lundbeck Inc.